Inactive Instrument

IQ3CORP

Equities

IQ3

AU000000IQ36

IQ3Corp Limited Appoints George Syrmalis as Chief Executive Officer

May 21, 2015 at 04:15 am EDT

iQ3Corp Ltd. announced the appointment of Dr. George Syrmalis as Chief Executive Officer. His depth of skills and expertise perfectly complement the company's Life Science focus and will help to further bolster iQ3Corp's scientific expertise. He has a detailed understanding of iQ3Corp's business and the needs of prospective clients.

Latest news about IQ3CORP

IQ3Corp Enters Voluntary Administration	22-03-11	MT
IQ3Corp Ltd Announces Executive Changes	22-01-12	CI
IQ3Corp Investee OncoTEX Secures Gold Compound Platform Technology License; iQ3Corp Shares Surge 15%	21-11-04	MT
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-27	CI
IQ3Corp Ltd Announces Executive Changes	21-05-03	CI
IQ3Corp Ltd Announces Resignation of Monika Pawel as Non-Executive Director	21-04-13	CI
IQ3Corp Limited Appoints Peter Mercouris as A Director	21-04-13	CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2020	21-02-23	CI
IQ3Corp Limited Announces Executive Changes	21-01-13	CI
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2020	20-08-27	CI
IQ3Corp Ltd Announces Board Changes	20-03-20	CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2019	20-02-28	CI
Iq3corp Ltd Reports Earnings Results for the Full Year Ended June 30, 2019	19-08-30	CI
IQ3 Corp Announces Executive Changes	19-08-27	CI
Iq3corp Ltd Reports Earnings Results for the Half Year Ended December 31, 2018	19-02-27	CI
IQ3Corp Limited Reports Consolidated Earnings Results for the Year Ended June 30, 2018	18-09-30	CI
Iq3corp Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2018	18-08-31	CI
IQ3Corp Limited Announces Address Changes	18-02-28	CI
IQ3Corp Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2017	18-02-26	CI
IQ3Corp Limited Announces Board Changes	18-02-13	CI
IQ3Corp Limited Announces Resignation of Spiro Sakiris from the Board	17-12-04	CI
Iq3corp Limited Reports Audited Consolidated Earnings Results for the Year Ended June 30, 2017	17-09-29	CI
IQ3Corp Limited Reports Preliminary Unaudited Consolidated Earnings Results for the Year Ended June 30, 2017	17-08-31	CI
IQ3Corp Limited Reports Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2016	17-02-28	CI
IQ3Corp Limited Announces Board Changes	16-08-22	CI

Chart IQ3CORP

Duration

Period

More charts

Company Profile

iQ3Corp Ltd is an Australia-based company that is engaged in the provision of capital raising and corporate advisory services to listed and unlisted companies in the life science industry. The Company's segments include consulting services and shared services. consulting services segment includes capital raising and corporate advisory fees. shared services segment includes office and shared services revenue. It provides advices to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance to corporations, partnerships, institutions, governments, and individuals. It offers various services, such as initial public offerings, listings, private equity, merger and acquisitions, sell-side advisory, buy-side advisory, structured finance and N.S.X. nominated advisor. The Company has six wholly owned subsidiaries.

Sector

More about the company